ADMA Biologics, Inc. (ADMA)

2,4600 -0,0100 (-0,40%) Alla chiusura: 4:00PM EST

ADMA Biologics, Inc.

465 State Route 17
Ramsey, NJ 07446
United States
201 478 5552
http://www.admabiologics.com

Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 313

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Adam S. Grossman	Co-Founder, Pres, CEO & Director	941,16k	N/D	1977
Dr. Jerrold B. Grossman Ph.D., D.P.S.	Co-Founder & Vice Chairman	70,9k	N/D	1948
Mr. Brian Lenz CPA, CPA	Exec. VP & CFO	741,73k	N/D	1972
Dr. James Mond	Exec. VP, Chief Scientific Officer & Chief Medical Officer	856,99k	N/D	1946
Ms. Kim Tripodo	Exec. Director & Head of Human Resource and Admin. Operations	N/D	N/D	N/D
Mr. Skyler Bloom	Director of Investor Relations & Corp. Strategy	N/D	N/D	N/D
Ms. Kaitlin Kestenberg	VP of Compliance, Project Management & Clinical Operations	N/D	N/D	N/D
Mr. Michael Least	VP of Sales & Commercial Operations	N/D	N/D	N/D
Mr. Drew Pantello	VP of Marketing & Corp. Devel.	N/D	N/D	N/D
Dr. Gene A. Wetzstein BCOP, Pharm.D.	Exec. Director & Head of Scientific Engagement	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2019 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

Governance aziendale

L'ISS Governance QualityScore di ADMA Biologics, Inc. al 22 gennaio 2021 è 7. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 6; diritti degli azionisti: 8; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.